JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Author:
Sanchez Gina A. Montealegre, Reinhardt Adam, Ramsey Suzanne, Wittkowski HelmutORCID, Hashkes Philip J., Berkun Yackov, Schalm Susanne, Murias Sara, Dare Jason A., Brown Diane, Stone Deborah L., Gao Ling, Klausmeier Thomas, Foell Dirk, de Jesus Adriana A., Chapelle Dawn C., Kim HannaORCID, Dill Samantha, Colbert Robert A., Failla Laura, Kost Bahar, O’Brien Michelle, Reynolds James C., Folio Les R., Calvo Katherine R.ORCID, Paul Scott M., Weir NarguesORCID, Brofferio Alessandra, Soldatos Ariane, Biancotto Angelique, Cowen Edward W., Digiovanna John J., Gadina Massimo, Lipton Andrew J., Hadigan Colleen, Holland Steven M.ORCID, Fontana Joseph, Alawad Ahmad S., Brown Rebecca J., Rother Kristina I., Heller Theo, Brooks Kristina M.ORCID, Kumar Parag, Brooks Stephen R.ORCID, Waldman Meryl, Singh Harsharan K.ORCID, Nickeleit Volker, Silk Maria, Prakash Apurva, Janes Jonathan M., Ozen Seza, Wakim Paul G., Brogan Paul A., Macias William L., Goldbach-Mansky Raphaela
Funder
NIAID NIAMS Eli Lilly and Company
Publisher
American Society for Clinical Investigation
Cited by
412 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|